1-3 of 3
Catia Moutinho
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent

Josep M. Piulats, August Vidal, Francisco J. García-Rodríguez, Clara Muñoz, Marga Nadal, Catia Moutinho, María Martínez-Iniesta, Josefina Mora, Agnés Figueras, Elisabet Guinó, Laura Padullés, Àlvaro Aytés, David G. Molleví, Sara Puertas, Carmen Martínez-Fernández, Wilmar Castillo, Merce Juliachs, Victor Moreno, Purificación Muñoz, Milica Stefanovic, Miguel A. Pujana, Enric Condom, Manel Esteller, Josep R. Germà, Gabriel Capella, Lourdes Farré, Albert Morales, Francesc Viñals, Xavier García-del-Muro, Julián Cerón, Alberto Villanueva
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15): 3755–3766.
https://doi.org/10.1158/1078-0432.CCR-17-1898
Published: 31 July 2018
View articletitled, Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent
Open the PDF for Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent in another window
Includes: Supplementary data
Journal Articles

Promoter CpG Island Hypermethylation of the DNA Repair Enzyme MGMT Predicts Clinical Response to Dacarbazine in a Phase II Study for Metastatic Colorectal Cancer

Alessio Amatu, Andrea Sartore-Bianchi, Catia Moutinho, Alessandro Belotti, Katia Bencardino, Giuseppe Chirico, Andrea Cassingena, Francesca Rusconi, Anna Esposito, Michele Nichelatti, Manel Esteller, Salvatore Siena
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (8): 2265–2272.
https://doi.org/10.1158/1078-0432.CCR-12-3518
Published: 15 April 2013
View articletitled, Promoter CpG Island Hypermethylation of the DNA Repair Enzyme MGMT Predicts Clinical Response to Dacarbazine in a Phase II Study for Metastatic Colorectal Cancer
Open the PDF for Promoter CpG Island Hypermethylation of the DNA Repair Enzyme MGMT Predicts Clinical Response to Dacarbazine in a Phase II Study for Metastatic Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract PR3: Patient derived BRCA1-deficient triple-negative breast cancer xenografts develop resistance to DNA damaging agents via genetic and epigenetic mechanisms

Petra ter Brugge, Jelle Wesseling, Jos Jonkers, Eline van der Burg, Petra Kristel, Ute Boon, Cátia Moutinho, Manel Esteller, Frans Hogervorst, Heidrun Gevensleber, Nicholas Turner
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (10_Supplement): PR3.
https://doi.org/10.1158/1078-0432.MECHRES-PR3
Published: 04 March 2013
View articletitled, Abstract PR3: Patient derived BRCA1-deficient triple-negative breast cancer xenografts develop resistance to DNA damaging agents via genetic and epigenetic mechanisms
Open the PDF for Abstract PR3: Patient derived BRCA1-deficient triple-negative breast cancer xenografts develop resistance to DNA damaging agents via genetic and epigenetic mechanisms in another window